Fragment-065

Not inhibitor of Notum Compound 4 Fragment 065 IC50 54+/-16 microM

General

Type : Fragment inhibitor of Notum,Benzimidazole

Chemical_Nomenclature : [4-(benzimidazol-1-yl)phenyl]methanol

Canonical SMILES : C1=CC=C2C(=C1)N=CN2C3=CC=C(C=C3)CO

InChI : InChI=1S\/C14H12N2O\/c17-9-11-5-7-12(8-6-11)16-10-15-13-3-1-2-4-14(13)16\/h1-8,10,17H,9H2

InChIKey : IRZKUEWQJPIBJF-UHFFFAOYSA-N

Other name(s) : Fragment 065,Compound 4,JFS,[4-(1H-1,3-benzimidazol-1-yl)phenyl]methanol,[4-(1H-benzimidazol-1-yl)phenyl]methanol,(4-(1H-Benzo[d]imidazol-1-yl)phenyl)methanol,[4-(1H-1,3-benzodiazol-1-yl)phenyl]methanol,SCHEMBL12970574,ZINC168836


MW : 224.26

Formula : C14H12N2O

CAS_number : 451485-67-9

PubChem : 2763828

UniChem : IRZKUEWQJPIBJF-UHFFFAOYSA-N

IUPHAR :

Wikipedia :

Target

Families : Fragment-065 ligand of proteins in family: Pectinacetylesterase-Notum

Stucture : 7B84 Structure of the human Wnt deacylase Notum in complex with fragment 065

Protein : human-NOTUM

References (1)

Title : Structural Analysis and Development of Notum Fragment Screening Hits - Zhao_2022_ACS.Chem.Neurosci_13_2060
Author(s) : Zhao Y , Mahy W , Willis NJ , Woodward HL , Steadman D , Bayle ED , Atkinson BN , Sipthorp J , Vecchia L , Ruza RR , Harlos K , Jeganathan F , Constantinou S , Costa A , Kjaer S , Bictash M , Salinas PC , Whiting P , Vincent JP , Fish PV , Jones EY
Ref : ACS Chem Neurosci , 13 :2060 , 2022
Abstract : Zhao_2022_ACS.Chem.Neurosci_13_2060
ESTHER : Zhao_2022_ACS.Chem.Neurosci_13_2060
PubMedSearch : Zhao_2022_ACS.Chem.Neurosci_13_2060
PubMedID: 35731924
Gene_locus related to this paper: human-NOTUM